Present and future etiological treatment of bacterial pneumonia 3. The antibacterial drugs under development

Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 5

Abstract

The rapid spread of antibiotic-resistant bacterial strains necessitates the development of new antibacterial agents and a review of the guidelines for etiological treatment of bacterial infections, including pneumonia. Currently, new antibacterial agents are being developed that disrupt the biosynthesis of peptidoglycan, teichoic and lipoteichoic acids, and also block the attachment of virulent factors to the bacterial wall. New molecules of old classes of antibiotics and representatives of new classes of antibiotics with their targets (lipid II and III, teichoic and lipoteichoic acids, alanine racemase, and sortase A) will become practical tools in clinical practice in the very near future. The goals and mechanisms of action of new antibacterial compounds predetermine their clinical prospects in future strategies for the treatment of infectious bacterial diseases.

Authors and Affiliations

А. Е. Abaturov, Т. А. Kryuchko

Keywords

Related Articles

The Effectiveness of Herbion Iceland Moss Syrup in the Treatment of Dry Cough in Children

The article presents the etiologic and pathogenetic aspects of the appearance of dry cough in children. Personal experience of using Herbion Iceland moss syrup in the treatment of post-infectious dry cough in children ag...

Tocilizumab in the Treatment of Juvenile Rheumatoid Arthritis

In the development of rheumatic diseases, especially juvenile rheumatoid arthritis, the important role of some cytokines, most important of which are interleukin-1, interleukin-6 and tumor necrosis factor α, has been pro...

Prediction and diagnosis of right ventricular heart failure and ventricular dysfunction during the exacerbation of bronchial asthma in children

Background. Bronchial asthma (BA) already in childhood can be accompanied by cardiovascular complications in the form of acute pulmonary heart disease, ventricular dysfunction, metabolic cardiomyopathy, rhythm and conduc...

Activation of Antioxidant Defense and Inhibition of Lipid Peroxidation on the Background of Combination Treatment of Children with Oral Mucosal Inflammatory Diseases

The authors present clinical and biochemical results of determining the parameters of the system « lipid peroxidation — antioxidant defense » on the background of combination treatment of children with oral mucosal infla...

Asymptomatic Hyperamylasemia in the Onset of Inflammatory Bowel Diseases in Children: A Case Report

The article analyzed the literature data on the epidemiology, etiology, mechanisms of pancreatic lesions in inflammatory bowel diseases in children. Range of pathological conditions of the pancreas in patients with infla...

Download PDF file
  • EP ID EP221470
  • DOI 10.22141/2224-0551.12.5.2017.109278
  • Views 78
  • Downloads 0

How To Cite

А. Е. Abaturov, Т. А. Kryuchko (2017). Present and future etiological treatment of bacterial pneumonia 3. The antibacterial drugs under development. Здоров`я дитини, 12(5), 590-603. https://europub.co.uk/articles/-A-221470